Congenital Heart Disease

Heart disease is a leading killer of U.S. men and women. Past studies on heart disease and coffee have been inconsistent, write Esther Lopez-Garcia, PhD, and colleagues in Circulation.
Lopez-Garcia works in Spain at the Universidad Autonoma de Madrid’s medical school. Her new study, done in collaboration with Harvard Medical School, checks data from two long-term U.S. health studies.

A study showing a higher death rate among heart disease patients one year after taking the Abbott Laboratories Inc. antibiotic Biaxin recently published in the British Medical Journal, evaluated data from about 4,373 Danish heart disease patients who took Biaxin (clarithromycin) or a placebo for 14 days.